Admunex Therapeutics
Manufacturing · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1700 Broadway, Denver, Colorado, 80202, ...Phone Number
(408) 245-0003Website
www.aminextx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Admunex Therapeutics
Aminex Therapeutics, Inc. is a drug development company dedicated to advancing a novel immunotherapy aimed at treating cancer. Their approach focuses on polyamine depletion therapy, which reduces the production of polyamines linked to immune system suppression, thereby activating the innate immune system to combat solid tumors. The company's drug candidate, AMXT 1501 + DFMO, is an oral small molecule therapy designed to synergistically enhance immune response against various solid tumor cancers. Their current clinical trials primarily target patients with breast cancer and melanoma.Explore more
Admunex Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Admunex Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Admunex Therapeutics had a recent Job posting/layoffs
Check if Admunex Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Admunex Therapeutics is spiking on competitors!
Product Launch: Get notified when Admunex Therapeutics launches new products
Admunex Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Admunex Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Admunex Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Admunex Therapeutics has new funding data
Recommended Actions
Find VP level buyers at Admunex Therapeutics
Find 2 more new buyers
Compare Similar Companies to Admunex Therapeutics
Compare insights from companies similar to Admunex Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Admunex Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Admunex Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Admunex Therapeutics.
Admunex Therapeutics financials insights
Gather financial insights about Admunex Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Private Equity
$1.6M
2015
Series A
$4M
Admunex Therapeutics Tech Stack
A closer look at the technologies used by Admunex Therapeutics
See more technologies
Admunex Therapeutics News & Media
Sydney Researchers Identify Potential New Drug Treatment Developed By Aminex Therapeutics For Fatal Childhood Cancer
SEATTLE, Feb. 16, 2021 /PRNewswire/ -- Every year around 20 Australian children die from the incurable brain tumor, Diffuse Intrinsic Pontine Glioma (DIPG). The average age of diagnosis for DIPG is just seven years. There are no effective treatments, and almost all children die from the...International Research Team Led by Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma
SEATTLE, Jan. 30, 2019 /PRNewswire/ -- The MYCN oncogene has long been known to be a key cause of a number of deadly solid tumour cancers, including neuroblastoma, which claims more lives of children under the age of 5 than any other cancer. Neuroblastoma is the most common solid tumour...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Admunex Therapeutics
Sign Up For FreeTo access detailed company insights
Aminex Therapeutics, Inc. is a drug development company dedicated to advancing a novel immunotherapy aimed at treating cancer. Their approach focuses on polyamine depletion therapy, which reduces the production of polyamines linked to immune system suppression, thereby activating the innate immune system to combat solid tumors. The company's drug c... Read More
